report_type_id: ms_biomarker_registry_health
version: "1.0.0"
title: "MS Biomarker Registry Health Report"
required_columns:
  - PID
  - SID
  - Sample Date
  - Last Date
  - Sample EDSS
  - Last EDSS
  - Sample Cours
  - Last Cours
metrics_profile: ms_biomarker_registry_health
default_prefs:
  tone: technical
  audience: leadership
  focus: trends
  high_missing_threshold: 0.60
  severe_missing_threshold: 0.85
  edss_worsened_alert_ratio: 0.40
  top_n_sparse_biomarkers: 12
  top_n_course_transitions: 12
  corr_min_pairs: 30
  strong_corr_threshold: 0.35
  weak_corr_threshold: 0.10
  top_n_corr_biomarkers: 15
  top_n_biomarker_pairs: 12
  min_biomarker_non_null: 100
  zscore_outlier_threshold: 2.0
  top_n_zscore_biomarkers: 12
  zscore_outlier_rows_limit: 25
  stat_corr_min_pairs: 20
  corr_band_very_weak_max: 0.10
  corr_band_weak_max: 0.29
  corr_band_moderate_max: 0.49
  corr_band_strong_max: 0.69
  corr_color_very_weak: "#6b7280"
  corr_color_weak: "#2563eb"
  corr_color_moderate: "#0f766e"
  corr_color_strong: "#b45309"
  corr_color_very_strong: "#b91c1c"
prompt_instructions: |
  Analyze this MS registry dataset with strong attention to data quality and longitudinal signal.
  Ignore biomarkers with non-null values below the configured minimum threshold.
  Include a dedicated section titled "Methods" written in scientific-paper style paragraphs (not bullets).
  Methods must clearly describe: study design/data source, preprocessing/missing-data handling, statistical tests/correlation method,
  EDSS banding strategy (0-3.5 vs 4+), outlier handling, and key analytical limitations.
  Must include:
  - participant coverage (unique PID, SID distribution, missingness profile)
  - handling of empty cells and impact on confidence
  - EDSS progression signal (improved / stable / worsened, with ratio)
  - biomarker-to-Sample-EDSS correlations (state contributing vs weak/non-contributing markers)
  - grouped biomarker correlations to Sample EDSS by two bands: 0-3.5 and 4+
  - grouped biomarker correlations to Last EDSS by two bands: 0-3.5 and 4+
  - z-score-based biomarker signal summary: top mean |z| in Sample EDSS 4+, outlier prevalence by biomarker, and top outlier rows
  - statistical validation checks: MAD robust z-score, IQR outlier rule, partial Spearman, Mann-Whitney U, Cliff's delta, permutation p-value, bootstrap CI, FDR correction, PCA latent factor, and longitudinal slope proxy
  - strongest biomarker-to-biomarker correlations and what clusters may indicate
  - disease-course transitions (sample vs last course)
  - biomarker panel completeness and which markers are too sparse for reliable inference
  Separate observed facts from inferred risk.
  Recommend practical next steps for data cleaning and follow-up analysis readiness.
output_schema:
  type: object
  additionalProperties: false
  required:
    - report_type_id
    - report_title
    - summary
    - sections
    - alerts
    - recommendations
    - tables
    - charts
    - metadata
  properties:
    report_type_id:
      type: string
    report_title:
      type: string
    summary:
      type: string
    sections:
      type: array
      items:
        type: object
        additionalProperties: false
        required: [title, body]
        properties:
          title: { type: string }
          body: { type: string }
    alerts:
      type: array
      items:
        type: object
        additionalProperties: false
        required: [severity, message]
        properties:
          severity: { type: string }
          message: { type: string }
    recommendations:
      type: array
      items:
        type: object
        additionalProperties: false
        required: [priority, action]
        properties:
          priority: { type: string }
          action: { type: string }
    tables:
      type: array
      items:
        type: object
        additionalProperties: true
    charts:
      type: array
      items:
        type: object
        additionalProperties: true
    metadata:
      type: object
      additionalProperties: true
